Protagenic Therapeutics, Inc. (PTIX)
NASDAQ: PTIX · Real-Time Price · USD
0.2120
-0.0028 (-1.30%)
Apr 25, 2025, 4:00 PM EDT - Market closed

Protagenic Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
23472311
Upgrade
Market Cap Growth
-24.17%-24.17%-36.49%-70.56%115.87%-24.82%
Upgrade
Enterprise Value
-02-0-11311
Upgrade
Last Close Price
0.220.490.991.605.544.20
Upgrade
PB Ratio
1.563.291.201.002.36-9.46
Upgrade
P/TBV Ratio
1.623.291.201.002.36-
Upgrade
Debt / Equity Ratio
---0.050.03-1.19
Upgrade
Quick Ratio
1.951.956.197.1312.971.02
Upgrade
Current Ratio
2.002.006.417.1813.831.34
Upgrade
Return on Equity (ROE)
-236.06%-236.06%-94.48%-42.18%-102.89%-
Upgrade
Return on Assets (ROA)
-113.49%-113.49%-45.78%-23.29%-43.35%-185.27%
Upgrade
Return on Capital (ROIC)
-152.23%-152.23%-51.77%-25.38%-49.36%-
Upgrade
Earnings Yield
-336.79%-165.95%-113.89%-51.42%-19.26%-23.43%
Upgrade
FCF Yield
-257.01%-126.64%-87.77%-28.86%-11.92%-12.40%
Upgrade
Buyback Yield / Dilution
-12.78%-12.78%-0.62%-17.17%-42.57%-0.76%
Upgrade
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q